| PFIZER  | 
The Current P/E Ratio of PFIZER  is 29.96.
                
| Share Price | ₹5,301.8 | Oct 30,2025 | 
| Market Cap | ₹24,229.0 Cr | |
| Earnings-TTM | ₹808.6 Cr | TTM-Standalone Results | 
| Price/Earnings | 29.96x | Calculated as Market Cap/Earnings | 
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of PFIZER
                    P/E = 
                    Market Capitalization 
                    / Net Income 
                    
                    or, using per-share numbers:
                    
                    P/E = Stock Price / 
                    Earnings Per Share (EPS)
                
               
                                     Current Market Cap [ ₹24,229.0 Cr] as on Oct 30,2025                     
                    (/) Earnings [ ₹808.6 Cr] based on TTM-Standalone Results
                                    
                
                (=) P/E Ratio [ 29.96x ]
            
Thus, for PFIZER , the investors are currently willing to pay 29.96 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of PFIZER !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of PFIZER over the last five years.
Historical PE (Price/Earnings) ratio chart of PFIZER
PE Ratio Performance Analysis for PFIZER
- PFIZER 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 31.63x.
- PFIZER 's operated at median p/e ratio of 32.5x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PFIZER 's p/e ratio peaked in Mar2021 at 41.57x.
- PFIZER 's p/e ratio hit its five-year low in Mar2025 of 23.86x.
How does PFIZER 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap | 
|---|---|---|---|
| PFIZER | 808.64 | 29.96 | 24,229.0 | 
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 39.26 | 408,751.0 | 
| DIVIS LABORATORIES LTD | 2,306.00 | 76.60 | 176,634.0 | 
| CIPLA LTD | 5,453.86 | 22.82 | 124,437.0 | 
| TORRENT PHARMACEUTICALS LTD | 2,002.00 | 60.87 | 121,871.0 | 
| DR REDDYS LABORATORIES LTD | 5,721.40 | 17.54 | 100,333.0 | 
| MANKIND PHARMA LTD | 1,905.51 | 52.98 | 100,950.0 | 
| ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.40 | 99,244.9 | 
| LUPIN LTD | 3,722.18 | 23.87 | 88,847.7 | 
| AUROBINDO PHARMA LTD | 3,417.93 | 18.73 | 64,033.4 | 
| ABBOTT INDIA LTD | 1,452.29 | 43.36 | 62,972.6 | 
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs PFIZER 's P/E Ratio
| Top 10 Industry Peers | PE Ratio | 
|---|---|
| Min industry PE | 17.54x | 
| Max industry PE | 76.60x | 
| Median industry PE | 29.96x | 
| Average industry PE | 37.04x | 
You may also like the below Video Courses
 
                                     
                                     
                                    